| Value | ₹0.03 Cr |
|---|---|
| Execution period | Vesting between 1 to 5 years; exercise within 1 year of vesting. |
NSE filing, NSE: WAKEFIT. Summary written from the filing by ALFA Finder's alert engine.
Wakefit Innovations Ltd: key numbers
- Share price
- ₹135.75
- Market cap
- ₹4,502 Cr
- Revenue (annual)
- ₹1,489 Cr
- Net profit (annual)
- ₹189.2 Cr
- P/E (TTM)
- 23.3×Sector 34.1×
- Promoter holding
- 37.07%+0.19% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wakefit Innovations Ltd
All →Wakefit Innovations Other Announcement
Wakefit Innovations Ltd has submitted the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has granted 2,25,442 employee stock options under its ESOP-2019 plan. These options are exercisable into equity shares at a price of Rs. 1 each.
Wakefit Innovations Management Change
Mr. Kunal Chandel, Senior Manager - Legal and Senior Management Personnel, has resigned from Wakefit Innovations Limited, effective from the close of business on September 24, 2026.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited held its 10th Annual General Meeting on September 09, 2026, through video conferencing to discuss and adopt financial matters.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has allotted 3,13,521 equity shares to employees following ESOP exercise. This increases the company's total paid-up equity share capital to 33,16,45,219 shares.
Wakefit Innovations Other Announcement
Wakefit Innovations Ltd is notifying shareholders with unregistered email addresses about how to access the Annual Report and AGM notice. This is a routine compliance communication.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date